{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:19:39Z","timestamp":1792757979723,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T00:00:00Z","timestamp":1569196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T00:00:00Z","timestamp":1569196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018\u201305133"],"award-info":[{"award-number":["2018\u201305133"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Methods"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1038\/s41592-019-0551-3","type":"journal-article","created":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T12:03:16Z","timestamp":1569240196000},"page":"1021-1028","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":245,"title":["Comprehensive mapping of neurotransmitter networks by MALDI\u2013MS imaging"],"prefix":"10.1038","volume":"16","author":[{"given":"Mohammadreza","family":"Shariatgorji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3779-3556","authenticated-orcid":false,"given":"Elva","family":"Fridjonsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodosia","family":"Vallianatou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"K\u00e4llback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luay","family":"Katan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"S\u00e4vmarker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Mantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0410-4638","authenticated-orcid":false,"given":"Erwan","family":"Bezard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Svenningsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7658-5103","authenticated-orcid":false,"given":"Luke R.","family":"Odell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4062-7743","authenticated-orcid":false,"given":"Per E.","family":"Andr\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,23]]},"reference":[{"key":"551_CR1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nrneurol.2015.172","volume":"11","author":"J Ng","year":"2015","unstructured":"Ng, J., Papandreou, A., Heales, S. J. & Kurian, M. A. Monoamine neurotransmitter disorders\u2014clinical advances and future perspectives. Nat. Rev. Neurol. 11, 567\u2013584 (2015).","journal-title":"Nat. Rev. Neurol."},{"key":"551_CR2","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1177\/10.3.348","volume":"10","author":"B Falck","year":"1962","unstructured":"Falck, B., Hillarp, N. A., Thieme, G. & Torp, A. Fluorescence of catechol amines and related compounds condensed with formaldehyde. J. Histochem. Cytochem. 10, 348\u2013354 (1962).","journal-title":"J. Histochem. Cytochem."},{"key":"551_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/cne.902610103","volume":"261","author":"BE Jones","year":"1987","unstructured":"Jones, B. E. & Beaudet, A. Distribution of acetylcholine and catecholamine neurons in the cat brainstem: a choline acetyltransferase and tyrosine hydroxylase immunohistochemical study. J. Comp. Neurol. 261, 15\u201332 (1987).","journal-title":"J. Comp. Neurol."},{"key":"551_CR4","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1021\/cr0782426","volume":"108","author":"SM Ametamey","year":"2008","unstructured":"Ametamey, S. M., Honer, M. & Schubiger, P. A. Molecular imaging with PET. Chem. Rev. 108, 1501\u20131516 (2008).","journal-title":"Chem. Rev."},{"key":"551_CR5","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.1021\/ac970888i","volume":"69","author":"RM Caprioli","year":"1997","unstructured":"Caprioli, R. M., Farmer, T. B. & Gile, J. Molecular imaging of biological samples: localization of peptides and proteins using MALDI\u2013TOF MS. Anal. Chem. 69, 4751\u20134760 (1997).","journal-title":"Anal. Chem."},{"key":"551_CR6","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1021\/cr3004295","volume":"113","author":"JL Norris","year":"2013","unstructured":"Norris, J. L. & Caprioli, R. M. Analysis of tissue specimens by matrix-assisted laser desorption\/ionization imaging mass spectrometry in biological and clinical research. Chem. Rev. 113, 2309\u20132342 (2013).","journal-title":"Chem. Rev."},{"key":"551_CR7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nmeth.4071","volume":"14","author":"M Kompauer","year":"2017","unstructured":"Kompauer, M., Heiles, S. & Spengler, B. Atmospheric pressure MALDI mass spectrometry imaging of tissues and cells at 1.4-\u03bcm lateral resolution. Nat. Methods 14, 90\u201396 (2017).","journal-title":"Nat. Methods"},{"key":"551_CR8","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/nmeth.4504","volume":"14","author":"MK Passarelli","year":"2017","unstructured":"Passarelli, M. K. et al. The 3D OrbiSIMS-label-free metabolic imaging with subcellular lateral resolution and high mass-resolving power. Nat. Methods 14, 1175\u20131183 (2017).","journal-title":"Nat. Methods"},{"key":"551_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/(SICI)1098-2787(1998)17:5<337::AID-MAS2>3.0.CO;2-S","volume":"17","author":"R Zenobi","year":"1998","unstructured":"Zenobi, R. & Knochenmuss, R. Ion formation in MALDI mass spectrometry. Mass Spectrom. Rev. 17, 337\u2013366 (1998).","journal-title":"Mass Spectrom. Rev."},{"key":"551_CR10","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neuron.2014.10.011","volume":"84","author":"M Shariatgorji","year":"2014","unstructured":"Shariatgorji, M. et al. Direct targeted quantitative molecular imaging of neurotransmitters in brain tissue sections. Neuron 84, 697\u2013707 (2014).","journal-title":"Neuron"},{"key":"551_CR11","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1021\/ac00080a016","volume":"66","author":"JME Quirke","year":"1994","unstructured":"Quirke, J. M. E., Adams, C. L. & Vanberkel, G. J. Chemical derivatization for electrospray-ionization mass-spectrometry 1. alkyl-halides, alcohols, phenols, thiols, and amines. Anal. Chem. 66, 1302\u20131315 (1994).","journal-title":"Anal. Chem."},{"key":"551_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jchromb.2016.06.011","volume":"1028","author":"MS Bergh","year":"2016","unstructured":"Bergh, M. S., Bogen, I. L., Lundanes, E. & Oiestad, A. M. L. Validated methods for determination of neurotransmitters and metabolites in rodent brain tissue and extracellular fluid by reversed phase UHPLC\u2013MS\/MS. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 1028, 120\u2013129 (2016).","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"551_CR13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.tins.2007.03.006","volume":"30","author":"A Bjorklund","year":"2007","unstructured":"Bjorklund, A. & Dunnett, S. B. Dopamine neuron systems in the brain: an update. Trends Neurosci. 30, 194\u2013202 (2007).","journal-title":"Trends Neurosci."},{"key":"551_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1124\/pr.56.3.1","volume":"56","author":"G Eisenhofer","year":"2004","unstructured":"Eisenhofer, G., Kopin, I. J. & Goldstein, D. S. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharm. Rev. 56, 331\u2013349 (2004).","journal-title":"Pharm. Rev."},{"key":"551_CR15","first-page":"1","volume":"5","author":"AW Tank","year":"2015","unstructured":"Tank, A. W. & Lee Wong, D. Peripheral and central effects of circulating catecholamines. Compr. Physiol. 5, 1\u201315 (2015).","journal-title":"Compr. Physiol."},{"key":"551_CR16","first-page":"413","volume":"174","author":"GR Breese","year":"1970","unstructured":"Breese, G. R. & Traylor, T. D. Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons. J. Pharm. Exp. Ther. 174, 413\u2013420 (1970).","journal-title":"J. Pharm. Exp. Ther."},{"key":"551_CR17","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1152\/jn.00620.2011","volume":"107","author":"NR Herr","year":"2012","unstructured":"Herr, N. R. et al. In vivo voltammetry monitoring of electrically evoked extracellular norepinephrine in subregions of the bed nucleus of the stria terminalis. J. Neurophysiol. 107, 1731\u20131737 (2012).","journal-title":"J. Neurophysiol."},{"key":"551_CR18","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/0364-7722(81)90046-1","volume":"5","author":"AS Chiu","year":"1981","unstructured":"Chiu, A. S., Godse, D. D. & Warsh, J. J. Determination of brain regional normetanephrine levels by liquid chromatography with electrochemical detection (LC\u2013EC). Prog. Neuropsychopharmacol. 5, 559\u2013563 (1981).","journal-title":"Prog. Neuropsychopharmacol."},{"key":"551_CR19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bbr.2014.07.037","volume":"277","author":"M Polotis","year":"2015","unstructured":"Polotis, M. & Niccolini, F. Serotonin in Parkinson\u2019s disease. Behav. Brain Res. 277, 136\u2013145 (2015).","journal-title":"Behav. Brain Res"},{"key":"551_CR20","first-page":"99","volume":"99","author":"RL Albin","year":"2006","unstructured":"Albin, R. L. Neurobiology of basal ganglia and Tourette syndrome: striatal and dopamine function. Adv. Neurol. 99, 99\u2013106 (2006).","journal-title":"Adv. Neurol."},{"key":"551_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1523\/JNEUROSCI.4058-06.2007","volume":"27","author":"H Kita","year":"2007","unstructured":"Kita, H., Chiken, S., Tachibana, Y. & Nambu, A. Serotonin modulates pallidal neuronal activity in the awake monkey. J. Neurosci. 27, 75\u201383 (2007).","journal-title":"J. Neurosci."},{"key":"551_CR22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1042\/bj0850447","volume":"85","author":"S Kveder","year":"1962","unstructured":"Kveder, S., Iskric, S. & Keglevic, D. 5-Hydroxytryptophol\u2014a metabolite of 5-hydroxytryptamine in rats. Biochem. J. 85, 447 (1962).","journal-title":"Biochem. J."},{"key":"551_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/cne.902220107","volume":"222","author":"P Panula","year":"1984","unstructured":"Panula, P., Revuelta, A. V., Cheney, D. L., Wu, J. Y. & Costa, E. An immunohistochemical study on the location of GABAergic neurons in rat septum. J. Comp. Neurol. 222, 69\u201380 (1984).","journal-title":"J. Comp. Neurol."},{"key":"551_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0169-328X(96)00200-8","volume":"44","author":"M Yasumi","year":"1997","unstructured":"Yasumi, M., Sato, K., Shimada, S., Nishimura, M. & Tohyama, M. Regional distribution of GABA transporter 1 (GAT1) mRNA in the rat brain: comparison with glutamic acid decarboxylase67 (GAD67) mRNA localization. Brain Res. Mol. Brain Res. 44, 205\u2013218 (1997).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"551_CR25","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.neuroscience.2006.12.001","volume":"145","author":"H Wang","year":"2007","unstructured":"Wang, H., Katz, J., Dagostino, P. & Soghomonian, J. J. Unilateral 6-hydroxydopamine lesion of dopamine neurons and subchronic l-DOPA administration in the adult rat alters the expression of the vesicular GABA transporter in different subsets of striatal neurons and in the substantia nigra, pars reticulata. Neuroscience 145, 727\u2013737 (2007).","journal-title":"Neuroscience"},{"key":"551_CR26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0006-8993(00)02758-X","volume":"879","author":"T Kageyama","year":"2000","unstructured":"Kageyama, T. et al. The 4F2hc\/LAT1 complex transports l-DOPA across the blood\u2013brain barrier. Brain Res. 879, 115\u2013121 (2000).","journal-title":"Brain Res"},{"key":"551_CR27","doi-asserted-by":"publisher","first-page":"12079","DOI":"10.1073\/pnas.96.21.12079","volume":"96","author":"RJ Boado","year":"1999","unstructured":"Boado, R. J., Li, J. Y., Nagaya, M., Zhang, C. & Pardridge, W. M. Selective expression of the large neutral amino acid transporter at the blood\u2013brain barrier. Proc. Natl Acad. Sci. USA 96, 12079\u201312084 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"551_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00415-006-3009-3","volume":"253","author":"M Murata","year":"2006","unstructured":"Murata, M. Pharmacokinetics of l-dopa\u2014special reference to food and aging. J. Neurol. 253, 47\u201352 (2006).","journal-title":"J. Neurol."},{"key":"551_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1385\/MN:28:3:209","volume":"28","author":"W Meissner","year":"2003","unstructured":"Meissner, W. et al. Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson\u2019s disease. Mol. Neurobiol. 28, 209\u2013218 (2003).","journal-title":"Mol. Neurobiol."},{"key":"551_CR30","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/35086062","volume":"2","author":"E Bezard","year":"2001","unstructured":"Bezard, E., Brotchie, J. M. & Gross, C. E. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nat. Rev. Neurosci. 2, 577\u2013588 (2001).","journal-title":"Nat. Rev. Neurosci."},{"key":"551_CR31","doi-asserted-by":"publisher","first-page":"7979","DOI":"10.1007\/s00216-018-1420-0","volume":"410","author":"MC Bagley","year":"2018","unstructured":"Bagley, M. C., Ekelof, M., Rock, K., Patisaul, H. & Muddiman, D. C. IR-MALDESI mass spectrometry imaging of underivatized neurotransmitters in brain tissue of rats exposed to tetrabromobisphenol A. Anal. Bioanal. Chem. 410, 7979\u20137986 (2018).","journal-title":"Anal. Bioanal. Chem."},{"key":"551_CR32","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1007\/s13361-016-1475-0","volume":"27","author":"AM Fernandes","year":"2016","unstructured":"Fernandes, A. M. et al. Direct visualization of neurotransmitters in rat brain slices by desorption electrospray ionization mass spectrometry imaging (DESI\u2013MS). J. Am. Soc. Mass Spectrom. 27, 1944\u20131951 (2016).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"551_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-015-0926-0","volume":"12","author":"C Esteve","year":"2016","unstructured":"Esteve, C., Tolner, E. A., Shyti, R., van den Maagdenberg, A. M. & McDonnell, L. A. Mass spectrometry imaging of amino neurotransmitters: a comparison of derivatization methods and application in mouse brain tissue. Metabolomics 12, 30 (2016).","journal-title":"Metabolomics"},{"key":"551_CR34","doi-asserted-by":"publisher","first-page":"13580","DOI":"10.1021\/acs.analchem.8b03746","volume":"90","author":"I Kaya","year":"2018","unstructured":"Kaya, I. et al. On-tissue chemical derivatization of catecholamines using 4-(N-Methyl)pyridinium boronic acid for ToF-SIMS and LDI-ToF mass spectrometry imaging. Anal. Chem. 90, 13580\u201313590 (2018).","journal-title":"Anal. Chem."},{"key":"551_CR35","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1523\/JNEUROSCI.15-03-01714.1995","volume":"15","author":"BJ Ciliax","year":"1995","unstructured":"Ciliax, B. J. et al. The dopamine transporter: immunochemical characterization and localization in brain. J. Neurosci. 15, 1714\u20131723 (1995).","journal-title":"J. Neurosci."},{"key":"551_CR36","doi-asserted-by":"publisher","first-page":"5636","DOI":"10.1002\/anie.201501892","volume":"54","author":"WJ Ramsay","year":"2015","unstructured":"Ramsay, W. J. et al. Designed enclosure enables guest binding within the 4200\u2009\u212b3 cavity of a self-assembled cube. Angew. Chem. Int. Ed. Engl. 54, 5636\u20135640 (2015).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"551_CR37","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.neuropharm.2008.03.005","volume":"54","author":"X Zhang","year":"2008","unstructured":"Zhang, X., Andren, P. E., Chergui, K. & Svenningsson, P. Neurokinin B\/NK3 receptors exert feedback inhibition on l-DOPA actions in the 6-OHDA lesion rat model of Parkinson\u2019s disease. Neuropharmacology 54, 1143\u20131152 (2008).","journal-title":"Neuropharmacology"},{"key":"551_CR38","doi-asserted-by":"publisher","first-page":"e14053","DOI":"10.1371\/journal.pone.0014053","volume":"5","author":"PO Fernagut","year":"2010","unstructured":"Fernagut, P. O. et al. Dopamine transporter binding is unaffected by l-DOPA administration in normal and MPTP-treated monkeys. PLoS One 5, e14053 (2010).","journal-title":"PLoS One"},{"key":"551_CR39","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1172\/JCI59426","volume":"122","author":"G Porras","year":"2012","unstructured":"Porras, G. et al. PSD-95 expression controls l-DOPA dyskinesia through dopamine D1 receptor trafficking. J. Clin. Invest 122, 3977\u20133989 (2012).","journal-title":"J. Clin. Invest"},{"key":"551_CR40","doi-asserted-by":"publisher","first-page":"e12322","DOI":"10.1371\/journal.pone.0012322","volume":"5","author":"E Santini","year":"2010","unstructured":"Santini, E. et al. Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in l-DOPA-induced dyskinesia. PLoS One 5, e12322 (2010).","journal-title":"PLoS One"},{"key":"551_CR41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0006-8993(97)00531-3","volume":"766","author":"E Bezard","year":"1997","unstructured":"Bezard, E., Imbert, C., Deloire, X., Bioulac, B. & Gross, C. E. A chronic MPTP model reproducing the slow evolution of Parkinson\u2019s disease: evolution of motor symptoms in the monkey. Brain Res. 766, 107\u2013112 (1997).","journal-title":"Brain Res."},{"key":"551_CR42","doi-asserted-by":"publisher","first-page":"6853","DOI":"10.1523\/JNEUROSCI.21-17-06853.2001","volume":"21","author":"E Bezard","year":"2001","unstructured":"Bezard, E. et al. Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson\u2019s disease. J. Neurosci. 21, 6853\u20136861 (2001).","journal-title":"J. Neurosci."},{"key":"551_CR43","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1006\/nbdi.2000.0375","volume":"8","author":"E Bezard","year":"2001","unstructured":"Bezard, E., Ravenscroft, P., Gross, C. E., Crossman, A. R. & Brotchie, J. M. Upregulation of striatal preproenkephalin gene expression occurs before the appearance of parkinsonian signs in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys. Neurobiol. Dis. 8, 343\u2013350 (2001).","journal-title":"Neurobiol. Dis."},{"key":"551_CR44","doi-asserted-by":"publisher","first-page":"28ra28","DOI":"10.1126\/scitranslmed.3000664","volume":"2","author":"MR Ahmed","year":"2010","unstructured":"Ahmed, M. R. et al. Lentiviral overexpression of GRK6 alleviates l-DOPA-induced dyskinesia in experimental Parkinson\u2019s disease. Sci. Transl. Med 2, 28ra28 (2010).","journal-title":"Sci. Transl. Med"},{"key":"551_CR45","doi-asserted-by":"publisher","first-page":"21824","DOI":"10.1073\/pnas.1012071107","volume":"107","author":"S Fasano","year":"2010","unstructured":"Fasano, S. et al. Inhibition of Ras\u2013guanine nucleotide-releasing factor 1 (Ras\u2013GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia. Proc. Natl Acad. Sci. USA 107, 21824\u201321829 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"551_CR46","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1093\/brain\/awn235","volume":"131","author":"A Munoz","year":"2008","unstructured":"Munoz, A. et al. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of l-DOPA-induced dyskinesia. Brain 131, 3380\u20133394 (2008).","journal-title":"Brain"},{"key":"551_CR47","doi-asserted-by":"publisher","first-page":"a009308","DOI":"10.1101\/cshperspect.a009308","volume":"2","author":"G Porras","year":"2012","unstructured":"Porras, G., Li, Q. & Bezard, E. Modeling Parkinson\u2019s disease in primates: the MPTP model. Cold Spring Harb. Perspect. Med. 2, a009308 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"551_CR48","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1021\/acs.analchem.5b04603","volume":"88","author":"P Kallback","year":"2016","unstructured":"Kallback, P., Nilsson, A., Shariatgorji, M. & Andren, P. E. msIQuant\u2014quantitation software for mass spectrometry imaging enabling fast access, visualization, and analysis of large data sets. Anal. Chem. 88, 4346\u20134353 (2016).","journal-title":"Anal. Chem."}],"container-title":["Nature Methods"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41592-019-0551-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41592-019-0551-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41592-019-0551-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:09:49Z","timestamp":1684606189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41592-019-0551-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,23]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["551"],"URL":"https:\/\/doi.org\/10.1038\/s41592-019-0551-3","relation":{},"ISSN":["1548-7091","1548-7105"],"issn-type":[{"value":"1548-7091","type":"print"},{"value":"1548-7105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,23]]},"assertion":[{"value":"20 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}